Characteristics of symptomatic reflux episodes on Acid suppressive therapy. - Wikidata - wikimedia - TriplyDB

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

http://www.wikidata.org/entity/Q46620477

about

Rationale for targeting pepsin in the treatment of reflux disease.Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.GERD assessment including pH metry predicts a high response rate to PPI standard therapy Challenges of correlating pH change with relief of clinical symptoms in gastro esophageal reflux disease: a phase III, randomized study of Zegerid versus Losec.Diagnosis of supra-esophageal gastric reflux: correlation of oropharyngeal pH with esophageal impedance monitoring for gastro-esophageal reflux Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line Gastroesophageal reflux disease and tooth erosion Novel insights into esophageal diagnostic procedures.Alginate controls heartburn in patients with erosive and nonerosive reflux disease Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment.Airway reflux, cough and respiratory disease Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells.Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus.Mechanisms of reflux perception in gastroesophageal reflux disease: a review.Novel therapeutics for gastro-esophageal reflux symptoms.Critical analysis of esophageal multichannel intraluminal impedance monitoring 20 years later.NERD: an umbrella term including heterogeneous subpopulations.The neurophysiology of the esophagus.Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.Antireflux surgery for dysplastic Barrett.Current status of functional gastrointestinal evaluation in clinical practice.Role of Acid and weakly acidic reflux in gastroesophageal reflux disease off proton pump inhibitor therapy.Prevention of DNA damage in Barrett's esophageal cells exposed to acidic bile salts.Airway reflux.Distinction between patients with non-erosive reflux disease and functional heartburn.Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa.The role of weakly acidic reflux in proton pump inhibitor failure, has dust settled?Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?The effect of intravenous corticotropin-releasing hormone administration on esophageal sensitivity and motility in health.Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.Mucosal integrity and sensitivity to acid in the proximal esophagus in patients with gastroesophageal reflux disease.Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology.A reduced esophageal epithelial integrity in a subgroup of healthy individuals increases with proton pump inhibitor therapy.Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis

P2860

Q34139420-C54DA884-B435-4853-9C3C-91C3D17F889C Q34278144-83A271D8-D559-4C46-8194-4C8316F2998A Q34549954-53E775C0-1AEC-4AEF-B1E4-7258EA74E634 Q35112456-85AB4B99-8267-4D7C-9934-3A7DB1BFCC47 Q35113352-F83632DC-34AA-4088-8480-C058A78B3710 Q35580564-043875C6-3C7B-4FCD-9B11-B461EF07BF54 Q35614974-BACC709D-9BED-4411-86FE-78CFB4452A55 Q36146896-0D13312E-0136-4AA1-B341-E6AB2559FF7D Q36215537-A92A7FCC-7E1C-4B5D-913F-9921BF4262FB Q36219922-DCB4D44C-898B-480B-866F-B75A272DB7EB Q36373664-09F09151-55E6-41B5-AAC6-08EB630DA6DF Q36377218-DB24E3EA-B1F9-4E14-A081-B96BCA9947AE Q36443746-31884338-16EE-4F38-B16F-B5625966C868 Q37257357-09F34C5F-E03F-414A-9089-ACBE305CBC5A Q37277277-326E368A-9E0E-4748-A06E-1CCDCCBBD4B9 Q37345839-590D5001-E30F-49EE-86B9-47C14F475D3C Q37762466-19E59A08-61CA-4554-BFE8-BC332CA07E37 Q37973216-2DF97D90-6EC7-4D76-AC10-05CD71AB8551 Q38057369-79885298-6559-491A-BECF-ECB2D9E334CF Q38059706-C39122DF-D259-432D-AFC6-054C9A3F9C95 Q38092939-F2C496EA-CBC1-4131-9877-36B2E92B78D5 Q38151803-6A2F123F-1153-45B9-A7C5-7D41A7A75284 Q38154876-F0858E03-3E66-4148-824F-FF6D399E790F Q38210074-0E7BD7D1-A661-4557-ACDA-E8CD64146687 Q38365234-2BBBEF60-9280-4721-A840-C93AE7FBE3F3 Q38460143-08C7794D-C15C-4C69-AD08-6F55F6B8F4B6 Q38744449-49748447-D435-4705-BE92-3FEE63880189 Q38866997-8065FC55-AC67-4E79-886B-CA21443F67B7 Q42406587-9DC6BD13-FCCC-42DA-B35F-FBE744EE0559 Q42561813-B5D7510C-DFD6-40B9-A8E7-8A9914F1B58D Q42656069-C0B74600-9560-4E0B-91FA-896063BEAC07 Q45985042-7677842C-EF51-48C1-B3F4-FB2D8A929414 Q51088978-E67E0C8D-F741-41D1-9831-85E7DB238270 Q51610349-885022AB-2E3D-4C1F-A593-EEFC88D2F308 Q53096244-9D5A1C5C-FE55-45C9-B206-5904470C9F6F Q53620305-6016E573-DE73-4255-BA36-DDFDE1C9E3DF Q55167512-A5272ECB-0D8B-4953-88AA-C2847B8ABA88 Q58579746-5001BD50-46DA-4145-BB85-1CF9B0B2C1DE

P2860

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

http://www.wikidata.org/entity/Q46620477

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

@en

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

@nl

type

label

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

@en

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

@nl

prefLabel

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

@en

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

@nl

P1433

Q46620477-F75CF6FD-4354-4FBC-A513-69E0307A5FB1

P1476

Q46620477-2B84A62B-2F82-4953-8D5B-0AC4B16DD8C8

P2093

Q46620477-0BCCE421-3617-4816-950F-6E55B5059DE2

Q46620477-5E2D7D41-2A1C-46C6-94DE-5C58A5274772

Q46620477-6F904376-D935-4120-ADB5-4BD7180A565F

Q46620477-7F3D2456-DECD-4690-9B9A-A9459AE15E10

Q46620477-C96A5D8C-CD7E-4382-ACCD-44C691746A9E

P2860

Q46620477-16DB2C2F-43F0-450A-91FA-B68E6D800EF0

Q46620477-259B6FD5-AB60-44E0-B90C-8072C64A127A

Q46620477-30D74795-FBB6-482D-BA29-AF94CCCF657B

Q46620477-362D1B78-EB28-42AE-A50B-6380364812EB

Q46620477-404143BB-17D4-4922-B385-B54EB264F892

Q46620477-41613E0D-0A07-4F2E-B993-5431606A4B13

Q46620477-5CDA3046-8E51-4412-BBE2-E7A9199395B1

Q46620477-95AF909C-B088-4B4B-9143-964ADFA0C913

Q46620477-A5BBEBD2-1961-4E5E-819F-5FF17B805842

Q46620477-A689EB83-02CA-4247-A30A-ACAC1B830DED

P304

Q46620477-191F4403-31F7-4A5C-A1FA-7998114A1E92

P31

Q46620477-BC2852AA-2241-44E2-BB34-65669FA11A26

P356

Q46620477-EB1AF5B5-26A2-4E04-8BB6-969DF7F59699

P407

Q46620477-34E52145-5821-4E6F-BF56-4949C26B6400

P433

Q46620477-4325B483-1205-41B2-9B1B-7B9A3EDFFB02

P478

Q46620477-27985C17-3C2F-443B-B3A7-7C019B6251DC

P50

Q46620477-76125912-E1D0-4809-A36A-895F4A863E6C

P577

Q46620477-F4CDA13D-4C71-4FBB-8AC9-9F5ADBC6CAF8

P5875

Q46620477-55EB726E-8817-4C5B-AA43-992C7C648371

P698

Q46620477-C1C1F2B6-905A-4230-90FE-EFC93801FFC4

P356

J.1572-0241.2008.01791.X

P1433

The American Journal of Gastroenterology

P1476

Characteristics of symptomatic reflux episodes on Acid suppressive therapy.

@en

P2093

Amit Agrawal

http://www.w3.org/2001/XMLSchema#string

Donald O Castell

http://www.w3.org/2001/XMLSchema#string

Elizabeth G Hill

http://www.w3.org/2001/XMLSchema#string

Inder Mainie

http://www.w3.org/2001/XMLSchema#string

Marcelo F Vela

http://www.w3.org/2001/XMLSchema#string

P2860

Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring

Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux

Technology insight: The role of impedance testing for esophageal disorders.

Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux.

Determinants of perception of heartburn and regurgitation.

Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.

Controlled mechanical distension of the human oesophagus: sensory and biomechanical findings.

Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH.

Oesophageal wall stretch: the stimulus for distension induced oesophageal sensation.

P304

1090-1096

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2008.01791.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5407529

http://www.w3.org/2001/XMLSchema#string

P698

18445095

http://www.w3.org/2001/XMLSchema#string